P004 - Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early sta... by Petrakova, K., Petruzelka, L., Holanek, M., Svoboda, T., Benesova, V., Palacova, M., Kolarova, I., Bielcikova, Z., Chrapava, M.

Get full text

Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage brea... by Petrakova, K., Petruzelka, L., Holanek, M., Svoboda, T., Benesova, V., Palacova, M., Kolarova, I., Bielcikova, Z., Chrapava, M.

Get full text

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial by Baselga, José, Dr, Bradbury, Ian, PhD, Eidtmann, Holger, MD, Di Cosimo, Serena, MD, de Azambuja, Evandro, MD, Aura, Claudia, MD, Gómez, Henry, MD, Dinh, Phuong, MD, Fauria, Karine, PhD, Van Dooren, Veerle, MSc, Aktan, Gursel, MD, Goldhirsch, Aron, MD, Chang, Tsai-Wang, MD, Horváth, Zsolt, MD, Coccia-Portugal, Maria, MD, Domont, Julien, MD, Tseng, Ling-Min, MD, Kunz, Georg, MD, Sohn, Joo Hyuk, MD, Semiglazov, Vladimir, MD, Lerzo, Guillermo, MD, Palacova, Marketa, MD, Probachai, Volodymyr, MD, Pusztai, Lajos, DPhil, Untch, Michael, PhD, Gelber, Richard D, PhD, Piccart-Gebhart, Martine, PhD

Get full text

Factors, Predicting Failure of Adjuvant Hormonotherapy of Breast Carcinoma. A Study in Tamoxifen Treated Patients by Petrakova, K., Nenutil, R., Grell, P., Palacova, M., Vyzula, R.

Get full text

Tumour phenotype and characteristics of metastatic brain involvement in breast cancer patient by Svoboda, M, Fabian, P, Palacova, M, Prochazkova, M, Ondrova, B, Grell, P, Gombosova, J, Princ, D, Slampa, P, Vyzula, R

Get full text

Abstract P1-07-16: Triple-negative breast cancer: A single-centre retrospective cohort study of 408 TNBC cases with a focus on elderly patients by Svoboda, M, Navrátil, J, Palácová, M, Fabian, P, Bareková, L, Kabut, T, Coufal, O, Fait, V, Jurácek, J, Selingerová, I

Get full text

Abstract P4-22-02: Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V+TMZ or carboplatin (C) and paclitaxel (P)... by Diéras, V, Han, HS, Robson, ME, Palácová, M, Marcom, PK, Jager, A, Bondarenko, I, Citrin, D, Campone, M, Telli, ML, Domchek, SM, Friedlander, M, Kaufman, B, Ratajczak, C, Coates, A, Bonnet, P, Qin, Q, Qian, J, Giranda, VL, Shepherd, SP, Puhalla, S, Isakoff, SJ

Get full text

Abstract S2-05: Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA... by Han, HS, Diéras, V, Robson, ME, Palácová, M, Marcom, PK, Jager, A, Bondarenko, I, Citrin, D, Campone, M, Telli, ML, Domchek, SM, Friedlander, M, Kaufman, B, Ratajczak, C, Coates, A, Bonnet, P, Qin, Q, Qian, J, Giranda, VL, Shepherd, SP, Isakoff, SJ, Puhalla, S

Get full text